Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells
Leukemia · 2024-12 · 38 (12) · 2598-2613
DOI: 10.1038/s41375-024-02409-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, online erschienen am 18.09.2024. Verfasst von Laura Volta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation), Krebsliga Schweiz (Ligue Suisse Contre le Cancer), Universität Zürich (University of Zurich).
Abstract (Originalsprache)
CAR T-cell products targeting lineage-specific cell-of-origin antigens, thereby eliminating both tumor and healthy counterpart cells, are currently clinically approved therapeutics in B- and plasma-cell malignancies. While they represent a major clinical improvement, they are still limited in terms of efficacy by e.g. single, sometimes low-expressed antigen targeting, and in terms of safety by e.g., lack of on-off activity. Successful cell-of-origin non-discriminative targeting of heterogeneous hematopoietic stem and progenitor cell malignancies, such as acute myeloid leukemia (AML), will require antigen-versatile targeting and off-switching of effectors in order to then allow rescue by hematopoietic stem cell transplantation (HSCT), preventing permanent myeloablation. To address this, we developed adaptor-CAR (AdFITC-CAR) T-cells targeting fluoresceinated AML antigen-binding diabody adaptors. This platform enables the use of adaptors matching the AML-antigen-expression profile and conditional activity modulation. Combining adaptors significantly improved lysis of AML cells in vitro. In therapeutic xenogeneic mouse models, AdFITC-CAR T-cells co-administered with single diabody adaptors were as efficient as direct CAR T-cells, and combinatorial use of adaptors further enhanced therapeutic efficacy against both, cell lines and primary AML. Collectively, this study provides proof-of-concept that AdFITC-CAR T-cells and combinations of adaptors can efficiently enhance immune-targeting of AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Philochem AG, Otelfingen, Switzerland.
- Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland.
ORCID-Profile: Laura Volta, Christian Pellegrino, Christian Koch, Florin Schneiter, Marco M Buehler, Roberto De Luca, Chiara F Magnani, Markus G Manz
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
- Krebsliga Schweiz (Ligue Suisse Contre le Cancer)
- Universität Zürich (University of Zurich)
- Deutsche Krebshilfe (German Cancer Aid)
- EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
- ETH Lymphoma Challenge Grant
- Dr. Horst Böhlke Foundation
Zitieren
APA
Volta, L., Myburgh, R., Pellegrino, C., Koch, C., Maurer, M., Manfredi, F., Hofstetter, M., Kaiser, A., Schneiter, F., Müller, J., Buehler, M. M., De Luca, R., Favalli, N., Magnani, C. F., Schroeder, T., Neri, D., & Manz, M. G. (2024). Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells. Leukemia, 38(12), 2598-2613. https://doi.org/10.1038/s41375-024-02409-1
Vancouver
Volta L, Myburgh R, Pellegrino C, Koch C, Maurer M, Manfredi F, et al. Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells. Leukemia. 2024;38(12):2598-2613. doi:10.1038/s41375-024-02409-1
BibTeX
@article{Volta2024,
author = {Volta, Laura and Myburgh, Renier and Pellegrino, Christian and Koch, Christian and Maurer, Monique and Manfredi, Francesco and Hofstetter, Mara and Kaiser, Anne and Schneiter, Florin and Müller, Jan and Buehler, Marco M and De Luca, Roberto and Favalli, Nicholas and Magnani, Chiara F and Schroeder, Timm and Neri, Dario and Manz, Markus G},
title = {Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells},
journal = {Leukemia},
year = {2024},
volume = {38},
number = {12},
pages = {2598--2613},
doi = {10.1038/s41375-024-02409-1}
}
EUVIMED